- Supported exchanges /
- NASDAQ /
- CGTX.NASDAQ
Cognition Therapeutics Inc (CGTX NASDAQ) stock market data APIs
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.
Cognition Therapeutics Inc Financial Data Overview
0.4456 | |
0.4387 | |
- | |
0.4549 | |
0.4246 | |
0.34-2.95 | |
17 972 K | |
40 133 K | |
0 | |
-0.18 | |
1.354 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Cognition Therapeutics Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -58 609 000
- Earnings Per Share -0.93
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Cognition Therapeutics Inc Earnings via APIs
- Latest Release 2024-08-08
- EPS/Forecast -0.23
Get Cognition Therapeutics Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Get Cognition Therapeutics Inc latest news via APIs
Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX) is presenting in vivo preclinical results at the Society for Neuroscience’s annual meeting illuminating the ...
- CALENDAR OF EVENTS
- CLINICAL STUDY
- COGNITION THERAPEUTICS
- INC
- NASDAQ:CGTX
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: